A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations

Clinical trial NCT03010059 · COMPLETED

Trial details

NCT number

NCT03010059

Sponsor

Janssen Research & Development, LLC

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-02-06

Primary completion

2017-05-29

Enrollment

48

View on ClinicalTrials.gov